US Patent Issued to AXSOME MALTA on April 1 for "Methods of administering solriamfetol to lactating women" (New York Inventor)

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,263,145, issued on April 1, was assigned to AXSOME MALTA LTD. (Qormi, Malta).

"Methods of administering solriamfetol to lactating women" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein according to some embodiments is a method for decreasing the potential for adverse events from solriamfetol in an infant fed breast milk obtained from a subject treated with solriamfetol comprising: orally administering the solriamfetol to the subject at a daily dose of about 37.5 mg to about 300 mg; and feeding the infant breast milk from the subject at least about 5 hours after administering the solriamfetol to t...